JeanWrightMD
Radiation Oncology • Washington, DCBreast Cancer
Nominated Professor and Chair, University of North Carolina
Dr. Wright is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5255 Loughboro Road Northwest
Washington, DC 20016Phone+1 202-537-4788Fax+1 202-243-5271
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2004 - 2008
Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 2003 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
MD State Medical License 2013 - 2025
NC State Medical License 2024 - 2025
DC State Medical License 2013 - 2024
FL State Medical License 2008 - 2014
NY State Medical License 2004 - 2011
American Board of Radiology Radiation Oncology
Clinical Trials
- MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer Start of enrollment: 2011 Dec 27
- Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer Start of enrollment: 2013 Mar 01
- Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial Start of enrollment: 2016 Feb 01
Roles: Contact
Publications & Presentations
PubMed
- Routine review of patient-reported outcome data influences radiotherapy care: IMPROVE study results.Khinh Ranh Voong, Siyao Li, Chen Hu, Ori Shokek, Russell K Hales
Radiotherapy and Oncology. 2025-02-01 - 7 citationsHypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.Julia S Wong, Hajime Uno, Angela C Tramontano, Lauren Fisher, Catherine V Pellegrini
JAMA Oncology. 2024-10-01 - Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.Michael Jiang, Kerry Avery, Rosina Ahmed, Jana de Boniface, Sanjoy Chatterjee
European Journal of Surgical Oncology. 2024-10-01
Press Mentions
Adjuvant Tamoxifen Reduces 15-Year Risk of Recurrence in ‘Good Risk’ DCIS Without Radiation TherapyJanuary 10th, 2025- Tamoxifen Reduces Risk for Invasive Recurrence of DCISDecember 13th, 2024
- Giving More Options to Patients with DCISDecember 12th, 2024
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/jean-wright
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
